Fusion Pharmaceuticals Inc (FUSN)
21.50
+0.04
(+0.19%)
USD |
NASDAQ |
May 17, 16:00
21.50
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Total Assets (Quarterly): 323.81M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 323.81M |
| December 31, 2023 | 285.84M |
| September 30, 2023 | 253.38M |
| June 30, 2023 | 268.29M |
| March 31, 2023 | 266.55M |
| December 31, 2022 | 219.06M |
| September 30, 2022 | 238.49M |
| June 30, 2022 | 228.14M |
| March 31, 2022 | 235.96M |
| Date | Value |
|---|---|
| December 31, 2021 | 252.27M |
| September 30, 2021 | 268.30M |
| June 30, 2021 | 282.16M |
| March 31, 2021 | 297.31M |
| December 31, 2020 | 310.68M |
| September 30, 2020 | 312.06M |
| June 30, 2020 | 323.11M |
| March 31, 2020 | 73.39M |
| December 31, 2019 | 69.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
69.40M
Minimum
Dec 2019
323.81M
Maximum
Mar 2024
250.45M
Average
267.42M
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 102.29B |
| Landos Biopharma Inc | 29.90M |
| Perspective Therapeutics Inc | 278.29M |
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.98M |
| Shareholders Equity (Quarterly) | 241.83M |